NeuroRx and Relief Therapeutics were given the go-ahead from the independent Data Monitoring Committee (DMC) to continue their Phase IIb/III trial of RLF-100 (aviptadil) to treat respiratory failure in critically ill patients with Covid-19. No safety concerns were identified, allowing the trial will continue as planned to meet the full enrolment of 165 patients. When it comes to shipments, Yourway works at all hours to ensure that our couriers are available whenever needed – that includes picking up shipments 24/7, including weekends and holidays, with no cut-off times and no hidden fees.